← Eichor
Study identifier: NCT07682636 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Keloid Pathogenesis And Fibroblast Activation Study

Condition: Keloids · Fibroblast  ·  Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Keloids are benign fibroproliferative skin disorders characterized by excessive fibroblast activation and extracellular matrix deposition. The molecular mechanisms underlying keloid formation remain incompletely understood. This prospective observational study aims to investigate the biological characteristics of keloid tissue by comparing surgically resected keloid specimens with adjacent normal skin obtained from the same patients. Histological and molecular analyses, including histopathology, polymerase chain reaction (PCR), Western blotting, and related laboratory assays, will be performed to identify signaling pathways and key regulatory factors associated with fibroblast activation. The findings may improve the understanding of keloid pathogenesis and identify potential therapeutic targets for future treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Wang  ·  +86 18867961137  ·  wangshoujie@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The Fourth Affiliated Hospital of Zhejiang University School of MedicineJinhua, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07682636